Friday, January 11, 2008

NY State Court To Dismiss Celebrex Cases

Plaintiffs suing Pfizer Inc. over its Celebrex do not have reliable scientific evidence to prove the drug can cause heart attacks and strokes at the 200-milligram dose. The 200 milligram dose is the most commonly prescribe dose of the medication.

The ruling is similar to one in U.S. District Court in San Francisco, where Judge Breyer ruled in November that lawyers for the more than 3,000 plaintiffs failed to produce scientifically reliable evidence that Celebrex causes heart attacks or strokes when ingested at the 200 milligram a day dose. A Daubert challenge worked.